Related Experiment Videos
Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection
Cristina Prat1, Josep Domínguez, Carlos Rodrigo
1Serveis de Microbiologia, Hospital Universitari Germans Trias i Pujol, C/Canyet s/n, 08916 Badalona, Spain. crisprat@ns.hugtip.scs.es
Insights
Procalcitonin (PCT) serum levels can predict long-term kidney scarring in children with urinary tract infections (UTIs). Low PCT indicates a low risk of scarring, while elevated levels correlate with renal damage, proving more specific than CRP.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Biomarker Research
Background:
- Urinary tract infections (UTIs) in children risk kidney damage.
- Differentiating lower UTI from acute pyelonephritis is challenging due to non-specific early symptoms.
- Procalcitonin (PCT) is investigated as a marker for severe bacterial infections.
Purpose of the Study:
- To evaluate serum procalcitonin (PCT) concentration for distinguishing uncomplicated UTI from acute pyelonephritis with renal scarring in children.
- To assess PCT's utility in predicting long-term renal sequelae.
Main Methods:
- Serum PCT levels were measured using immunoluminometric assay in children with confirmed UTIs.
- Renal scarring was assessed 5-6 months post-infection using 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy.
- C-reactive protein (CRP) and leukocyte count were also analyzed for comparison.
Main Results:
- Serum PCT at presentation strongly correlated with the presence of renal scars (P < 0.001).
- PCT demonstrated high sensitivity (92.3%) and better specificity (61.9%) than CRP (34.4%) in identifying renal damage.
- PCT showed a high negative predictive value (97.5%) for renal scarring.
Conclusions:
- Low admission PCT levels are associated with a reduced risk of long-term renal scarring.
- Elevated PCT values at admission correlate with established renal scars.
- PCT is a more specific biomarker than CRP and leukocyte count for identifying children at risk of developing renal damage from UTI.
Background:
Urinary tract infection (UTI) in young children carries the risk of parenchymal damage and sequelae. The location of the infection within the urinary tract influences decisions regarding both therapeutics and follow-up. Because clinical features and laboratory markers of infection at an early age are not specific, it is difficult to make a distinction between lower UTI and acute pyelonephritis. Procalcitonin (PCT) has been studied as a marker of severe bacterial infection. The aim of this study was to test the usefulness of PCT concentration in serum to distinguish between uncomplicated UTI and severe acute pyelonephritis with renal scars.
Methods:
PCT was measured by immunoluminometric assay in serum samples from children with microbiologically documented infection. Severe renal involvement was assessed by 99mTc-dimercaptosuccinic acid gammagraphy done 5 to 6 months after the episode to check for the presence of parenchymal scars. C-reactive protein (CRP) and leukocyte count were also measured.
Results:
PCT at presentation showed a significant correlation (P < 0.001) with the presence of renal scars in children with UTI. Using a cutoff of 1 ng/ml for PCT and 20 mg/l for CRP, sensitivity and specificity in distinguishing between urinary tract infection with and without renal damage were 92.3 and 61.9%, respectively, for PCT and 92.3 and 34.4% for CRP. Positive and negative predictive values were 32 and 97.5%, respectively, for PCT and 23 and 95%, respectively, for CRP.
Conclusions:
A low PCT value at admission indicates a low risk of long term renal scarring. Increased PCT values at admission correlate with the presence of scars. PCT values have proved to be more specific than CRP and leukocyte count for identifying patients who might develop renal damage.
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi III: Medical Management